Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved a New Drug Application (NDA) for an Evrysdi® ...

As of December 31, 2024, the Company had cash and cash equivalents in the amount of $15.6 million, compared to $5.3 million ...

"The Evrysdi tablet combines established efficacy with convenience, providing an additional flexible option for SMA management." The approval of the Evrysdi tablet was based on the results of a ...

Evrysdi is the only non-invasive disease-modifying SMA treatment and is approved in over 100 countries Evrysdi tablet can be stored at room temperature and offers the same demonstrated efficacy and sa ...

The edition this year promises to redefine the standards of aerospace expositions and elevate India’s global presence in the ...

Unveiled on the inaugural day of the Global Investors Meet - Invest Karnataka 2025, the policy was officially introduced by ...

Investor Summit has drawn US$115 billion in investments, alongside the launch of its Industrial Policy 2025-30.

The Government of Karnataka launched its new industrial policy for 2025-30 at the inaugural session of Invest Karnataka 2025, the global investor meet being held in Bengaluru. The new policy aims to ...

Backlash over ‘performative cruelty’ as small boat refugees blocked from gaining citizenship - Criticism comes days after ...

What are the main concerns, how big of a factor is geopolitics, and what are the implications for global AI and tech?